Targeting Interleukin-4 Receptor With Hybrid Peptide for Effective Cancer Therapy
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0363
Full Text
Open PDFAbstract
Available in full text
Date
November 14, 2011
Authors
Publisher
American Association for Cancer Research (AACR)